The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members. [electronic resource]
Producer: 20160922Description: 192-8 p. digitalISSN:- 1569-8041
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.